Despite recent success in delineating the function and clinical relevance of tumor-infiltrating lymphocytes (TIL) including conventional CD3+ T cells and CD3−CD56+ NK cells in human GC [16, 17], the relationship between CD3+CD56+ NKT-like cells, another subset of TIL, and GC progression is completely unknown. This evidence concerns the gene NCAM1 and neoplasm.